Livelsberger Financial Advisory Abbott Laboratories Transaction History
Livelsberger Financial Advisory
- $6.7 Billion
- Q2 2024
A detailed history of Livelsberger Financial Advisory transactions in Abbott Laboratories stock. As of the latest transaction made, Livelsberger Financial Advisory holds 3,076 shares of ABT stock, worth $350,233. This represents 4.77% of its overall portfolio holdings.
Number of Shares
3,076
Previous 3,070
0.2%
Holding current value
$350,233
Previous $321 Million
0.57%
% of portfolio
4.77%
Previous 3.8%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.47 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.18 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.52 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...